Efficacy And Safety Of A Specific Inhibitor Of The BCR-ABL Tyrosine Kinase In Chronic Myeloid Leukemia

·2001·DOI

Health Sciences and Innovation

Biomedical Engineering

Cancer Research and Treatment

Cancer Treatment Response Evaluation

Role in the Field

Neutralin Health Sciences and Innovation

Neutralin Biomedical Engineering

Neutralin Cancer Research and Treatment

Neutralin Cancer Treatment Response Evaluation

Abstract

Citations

4,660

Year

2001

PageRank

5.5 / 10

Relative influence (log-scaled)

Related Papers

11 of 11 papers

The Molecular Signatures Database Hallmark Gene Set Collection

·2015·9,339 citations

PD-1 Blockade In Tumors With Mismatch-Repair Deficiency

·2015·7,826 citations

The Blockade Of Immune Checkpoints In Cancer Immunotherapy

·2012·11,288 citations

Safety, Activity, And Immune Correlates Of Anti–PD-1 Antibody In Cancer

·2012·10,804 citations

New Response Evaluation Criteria In Solid Tumours: Revised RECIST Guideline (Version 1.1)

·2009·23,079 citations

Comprehensive Genomic Characterization Defines Human Glioblastoma Genes And Core Pathways

·2008·6,780 citations

Bevacizumab Plus Irinotecan, Fluorouracil, And Leucovorin For Metastatic Colorectal Cancer

·2004·9,673 citations

Use Of Chemotherapy Plus A Monoclonal Antibody Against HER2 For Metastatic Breast Cancer That Overexpresses HER2

·2001·10,162 citations

New Guidelines To Evaluate The Response To Treatment In Solid Tumors

·2000·14,975 citations

Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group

·1982·8,462 citations

Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group.

·1982·6,775 citations